The information provided in this report is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.
AVROBIO, Inc(NASDAQ:AVRO) 
AVROBIO, Inc., a clinical-stage gene therapy company, develops ex vivo lentiviral-based gene therapies to treat rare diseases following a single dose worldwide. Its gene therapies employ hematopoietic stem cells that are collected from patients and modified with a lentiviral vector to insert functio...
Website: http://www.avrobio.com
Founded: 2015
Full Time Employees: 123
Sector: Healthcare
Industry: Biotechnology
AVROBIO Days Payable Outstanding ttm (DPO)
AVROBIO Op Cashflow Per Share ttm
AVROBIO Free Cashflow Per Share ttm
AVROBIO Cash Per Share ttm
AVROBIO (GAAP) P/E ratio ttm
AVROBIO P/B ratio ttm
No extra charts and metrics for this ticker.